Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
ENFN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.83 - $11.80
Previous CloseN/A
Volume130.23K
Average Volume (3M)1.32M
Market Cap
$1.46B
Enterprise Value$1.22B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)438.9
Beta0.62
Next Earnings
Mar 20, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding94,769,480
10 Day Avg. Volume1,193,153
30 Day Avg. Volume1,317,936
Standard Deviation0.15
R-Squared0.09
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.48
Price to Cash Flow (P/CF)22.60
P/FCF Ratio24.20
Enterprise Value/Market Cap0.84
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.46
Enterprise Value/Ebitda69.47
Forecast
1Y Price Target
$11.33Price Target Upside-1.48% Downside
Rating ConsensusHold
Number of Analyst Covering4
---
Bulls Say, Bears Say
Bulls Say
Market PositionEnfusion is well positioned to offer a solid balance of healthy growth and profitability, as it captures more traditional asset managers and larger clients through its expanded platform.
Shareholder SupportShareholders associated with FTV, ICONIQ, and CEO Oleg Movchan, representing approximately 45% of shares, have voiced support of the transaction.
Strategic ValueStrategic value has been unlocked for Enfusion with the proposed acquisition.
Bears Say
Competing BidThe likelihood of a competing bid is low, leading to a downgrade of Enfusion shares from Buy to Hold and a lowering of the target price.
Revenue OutlookEnfusion announced that it is tracking towards or beyond the low-end of its previously announced outlook, which implicitly decreases the probability of near-term revenue reacceleration.
Stock DowngradeThe stock rating has been downgraded from Overweight to Equal-weight.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.83 and its highest was $11.80 in the past 12 months.
What is Enfusion’s market cap?
Enfusion’s market cap is $1.46B.
When is Enfusion’s upcoming earnings report date?
Enfusion’s upcoming earnings report date is Mar 20, 2025 which is in 25 days.
How were Enfusion’s earnings last quarter?
Enfusion released its earnings results on Nov 04, 2024. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.057 by -$0.007.
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Overvalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate is 0.06.
How many shares outstanding does Enfusion have?
Enfusion has 94,769,480 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Enfusion reported an EPS of $0.05 in its last earnings report, missing expectations of $0.057. Following the earnings report the stock price went down -3.646%.
Which hedge fund is a major shareholder of Enfusion?
Currently, no hedge funds are holding shares in ENFN
---
Enfusion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.33 (-1.48% Downside)
$11.33 (-1.48% Downside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 65.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.00%
12-Months-Change
Fundamentals
Return on Equity
5.54%
Trailing 12-Months
Asset Growth
32.63%
Trailing 12-Months
Company Description
Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
---
ENFN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue and client growth, driven by strategic expansions and product innovations. However, challenges remain in the APAC region and with back book growth. The company's overall outlook remains positive, supported by strong market presence and innovative product developments.Read More>---
ENFN Stock 12 Month Forecast
Average Price Target
$11.33
▼(-1.48% Downside)
Technical Analysis
BlackRock
―
Broadridge Financial Solutions
―
Factset Research
―
Marketaxess Holdings
―
SS&C Technologies Holdings
―
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-9.55%
reiterated a sell rating 10 months ago
Copying Koji Ikeda's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -9.55% per trade.
---